30th June 2022, Seventh ParadigMS Symposium
ParadigMS Foundation organised organised in collaboration with the Belgian Multiple Sclerosis Study Group and endorsed by the Belgian Neurological Society, the ParadigMS Seventh Belgian Symposium that took place on the 30th of June both onsite and online. Here you can review the full keynote on Precision Medicine in MS.
ABSTRACT
Precision medicine is a relatively new concept that has gathered considerable attention over the past 10 years or so. Within the context of multiple sclerosis (MS), precision medicine involves the use of genetics, proteomics, advanced neuroimaging, and biomarkers to accurately define the disease in individuals. In this way, the objective is to improve clinical outcomes by providing patients with specific treatment and care through innovative approaches. This presentation by Prof Tjalf Ziemssen and Prof. Grigoriadis provides the background to precision medicine in MS and presents a roadmap showing how precision medicine can be implemented into today’s clinical care and treatment of MS patients.
TJALF ZIEMSSEN
University Clinic Carl-Gustav Carus, Dresden, Germany
Tjalf Ziemssen, MD, is Professor of Clinical Neuroscience in the Department of Neurology, Head of the Multiple Sclerosis Center and Neuroimmunological Laboratory, and Director of the Division of Neurometabolism at University Clinic Carl-Gustav Carus in Dresden, Germany. He earned his medical degree from the University of Bochum, Germany, and completed his neurology residency from University Hospital of Dresden, and neurobiology fellowship from Max-Planck-Institute of Neurobiology in Martinsried, Germany.
His research is focused on exploring the complex interaction between the neuroendocrinology system and the immune system and psychiatric symptoms, with a particular emphasis on stress in patients with obesity and depression and its pathologic influence on cardiovascular function using animal experimental and clinical approaches. Dr Ziemssen has authored several articles that have been published in peer-reviewed journals including BMC Neurology, Heart Vessels, Psychoneuroendocrinology, and Annals of Neurology. He is a member of the German Neurological Society, European Neurological Society, and American Academy of Neurology.
Media
